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Transcription Factor Tfec Contributes to the IL-4-Inducible
Expression of a Small Group of Genes in Mouse Macrophages
Including the Granulocyte Colony-Stimulating
Factor Receptor1
Michael Rehli,2,3*§ Sabine Sulzbacher,2* Sabine Pape,* Timothy Ravasi,† Christine A. Wells,†
Sven Heinz,* Liane So¨llner,* Carol El Chartouni,* Stefan W. Krause,* Eirikur Steingrimsson,‡
David A. Hume,† and Reinhard Andreesen*
Expression of the mouse transcription factor EC (Tfec) is restricted to the myeloid compartment, suggesting a function for Tfec
in the development or function of these cells. However, mice lacking Tfec develop normally, indicating a redundant role for Tfec
in myeloid cell development. We now report that Tfec is specifically induced in bone marrow-derived macrophages upon stim-
ulation with the Th2 cytokines, IL-4 and IL-13, or LPS. LPS induced a rapid and transient up-regulation of Tfec mRNA expression
and promoter activity, which was dependent on a functional NF-B site. IL-4, however, induced a rapid, but long-lasting, increase
in Tfec mRNA, which, in contrast to LPS stimulation, also resulted in detectable levels of Tfec protein. IL-4-induced transcription
of Tfec was absent in macrophages lacking Stat6, and its promoter depended on two functional Stat6-binding sites. A global
comparison of IL-4-induced genes in both wild-type and Tfec mutant macrophages revealed a surprisingly mild phenotype with
only a few genes affected by Tfec deficiency. These included the G-CSFR (Csf3r) gene that was strongly up-regulated by IL-4 in
wild-type macrophages and, to a lesser extent, in Tfec mutant macrophages. Our study also provides a general definition of the
transcriptome in alternatively activated mouse macrophages and identifies a large number of novel genes characterizing this cell
type. The Journal of Immunology, 2005, 174: 7111–7122.
T he differentiation of macrophages from hemopoietic pro-genitor cells requires the regulated expression of severalspecific transcription factors that control lineage commit-
ment, differentiation, and cell type-specific gene regulation. These
include members of the Ets, C/EBP, corticosterone-binding factor
families and several other transcription factors (1, 2). In particular,
transcription factors such as PU.1 that show a restricted or cell
type-specific expression pattern seem to play a major role in reg-
ulating macrophage differentiation (1–3). We previously showed
that the expression of mouse transcription factor EC (Tfec)4
mRNA is also restricted to cells of the monocyte-macrophage lin-
eage (4).
Tfec, a member of the microphthalmia-TFE (MiT) subfamily of
basic helix-loop-helix (bHLH) transcription factors, was originally
identified in a rat chondrosarcoma (2, 5). Although human TFEC
exists as multiple transcript variants resulting from alternative pro-
moter usage or alternative splicing that either contain or lack an
N-terminal activation domain (6, 7), rodents apparently express a
single isoform of Tfec without the N-terminal activation domain.
Early data suggested that Tfec forms homodimers or heterodimers
with other MiT proteins and acts as a transcriptional inhibitor (5).
More recent work indicates that both human and mouse Tfec con-
tain a C-terminal activation domain, and that the ability of Tfec to
repress or activate a reporter gene in transient cotransfection as-
says depends on both the promoter context and the cell type used
(6, 8, 9). The restricted expression of the mouse transcription fac-
tor Tfec is controlled by a typical TATA-less, myeloid-type pro-
moter that contains several Ets motifs that bind the myeloid- and
B cell-restricted transcription factor PU.1 (4). Although some mac-
rophage-related defect was anticipated based upon the expression
pattern, mice lacking Tfec are indistinguishable from their wild-
type littermates; they are viable and fertile, normally pigmented,
have normal eyes and mast cells, and show no osteopetrosis (10).
One possible explanation for the lack of a phenotype is that Tfec
in macrophages is coexpressed with the other known MiT mem-
bers (4) and is genuinely redundant. Alternatively, the penetrance
of mutations could be influenced by genetic background. For ex-
ample, the penetrance of mutations in both the related microph-
thalmia transcription factor and PU.1 is strongly influenced by
background genotype (11).
A third possibility is that Tfec has a nonredundant function in
some state of macrophage activation that is only required in re-
sponse to a particular challenge. Macrophages detect and respond
to a plethora of physiological and pathophysiological cues, includ-
ing microbial agents and a large number of chemo- and cytokines,
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with profound functional changes (12). The activation program of
mononuclear phagocytes, e.g., at sites of inflammation, is mainly
influenced by the local cytokine milieu. Although Th1 cytokines
and microbial agents induce classically activated macrophages that
produce proinflammatory mediators and effectively kill microor-
ganisms, Th2 cytokines, e.g., IL-4, support a distinct activation
program leading to alternatively activated macrophages that tune
inflammatory responses, promote tissue repair, and scavenge de-
bris (13). To gain insight into a possible regulatory role of Tfec in
activated macrophages under pathophysiological conditions, e.g.,
inflammation or cancer, we studied the expression of Tfec in mac-
rophages treated with different pro- and anti-inflammatory medi-
ators. Most strikingly, the Th2 cytokine IL-4 strongly induced Tfec
mRNA and protein in a Stat6-dependent fashion, implicating Tfec
as a secondary mediator of IL-4 signals in alternatively activated
macrophages. Using cDNA microarray analysis, we were able to
identify a small group of genes that are affected by Tfec deficiency
in mouse macrophages, including the G-CSFR gene (Csf3r) whose
up-regulation in IL-4-induced, alternatively activated macrophages
was at least partially Tfec dependent. Our analysis also provides a
global view of genes that shape the phenotype and function of
alternatively activated macrophages. In addition to Tfec, we iden-
tify a number of novel transcription factors, including muscle seg-
ment homeobox (msh)-like homeobox gene 3 (Msx3), early growth
response 2 (Egr2, Krox20), bHLH transcription factor STRA13/
Dec1 (Bhlhb2), IL-3-induced NF (Nfil3, E4bp4), Krueppel-like
factor 4 (Klf4, Gklf), basic transcription element-binding protein 1
(Bteb1), and ets variant gene 3 (Etv3, PE1/Mets), that are signif-
icantly induced by IL-4 and may act as secondary mediators of the
IL-4 response in mouse macrophages.
Materials and Methods
Chemicals
All chemical reagents used were purchased from Sigma-Aldrich unless
otherwise noted. Protease inhibitors were obtained from Roche. Oligonu-
cleotides were synthesized by TIB Molbiol. Antisera for supershift anal-
yses were purchased from Santa Cruz Biotechnology. Recombinant mouse
cytokines were purchased from PeproTech.
Cells
The cell line RAW264.7 (American Type Culture Collection) was culti-
vated in RPMI 1640 medium (BioWhittaker) and 10% FCS. To obtain
bone marrow-derived macrophages (BMM), bone marrow-derived den-
dritic cells (BMDC), or bone marrow-derived mast cells (BMMC), bone
marrow was extracted from the femurs of 8- to 12-wk-old mice. Cells from
several animals were pooled before plating into noncharged bacteriological
plates at 5  105 cells/ml. To obtain BMM, the cells were cultured in
RPMI 1640, 10% FCS, and 200 ng/ml human rCSF-1 (Cetus) for 5 days.
On day 5, the medium was replaced, and cells were harvested on day 6 and
replated at a density of 10  106 cells/10-cm tissue culture dish at 5  105
cells/ml, with CSF-1 added back overnight. Experimental time courses
were started on day 7. BMDC were obtained and cultured using mouse
rGM-CSF (10 ng/ml; PeproTech) as described by Lutz et al. (14). To
obtain BMMC, bone marrow cells were cultured in RPMI 1640 and 10%
FCS supplemented with stem cell factor (SCF; 50 ng/ml; PeproTech) and
IL-4 (40 ng/ml; PeproTech; treatment A) or with SCF (50 ng/ml; Pepro-
Tech) and IL-3 (5 ng/ml; PeproTech; treatment B). Medium and cytokines
were replaced every 3 days. Cells were harvested after 2 wk of culture.
Mice
BALB/c mice were obtained from Charles River Laboratories. The mutant
mouse strain deficient in Tfec (129Sv/J background) was generated by
gene targeting, as described previously (10).
Flow cytometry
BMM were harvested and resuspended in PBS containing 10% FCS (In-
vitrogen Life Technologies). FcRs were blocked using anti-CD16/32
(clone 2.4G2; BD Pharmingen) on ice for 30 min. Cells were stained with
PE-conjugated mAbs recognizing CD11b (Mac-1), CD115, CD204, F4/80
(all from Serotec), Ly-6G (Gr-1; BD Pharmingen), or isotype controls (Se-
rotec and BD Pharmingen) in the dark for 45 min on ice. After staining,
cells were washed twice with PBS containing 10% FCS. Analysis was
performed on a FACSCalibur flow cytometer (BD Biosciences).
RNA preparation and Northern blot analysis
Total RNA was isolated from different cell lines by the guanidine thiocy-
anate/acid phenol method. Electrophoresis, Northern blotting, and cDNA
hybridization were conducted as described previously using a 1200-bp
cDNA from Tfec coding region 4. Autoradiography was performed at
70°C, and bands were scanned with a Molecular Dynamics personal
densitometer.
Microarray analysis and data handling
Two independent microarray experiments were performed using two dif-
ferent microarray platforms. Firstly, cDNA from 16-h IL-4-treated BMM
(Tfec-deficient or wild type) were indirectly labeled with amino alyl-con-
jugated Cy3 (wild type) or Cy5 (Tfec/), as described at www.imb.u-
q.edu.au/groups/hume/, and hybridized at 65°C overnight to NIA 15K
mouse cDNA microarrays (SRC, Microarray Facility). Slides were washed
for 5 min in 2 SSC/0.2% SDS buffer and scanned on a ScanArray 5000
confocal laser scanner. Molecularware (Digital Genome) was used to pro-
cess the image, data were corrected for local background, and confidence
status was flagged for empty spots, signal/noise ratio, spot ratio variability,
and spot morphology. Data were imported into GeneSpring 4.2 (Silicon
Genetics) for clustering and comparative analysis. Differentially expressed
genes were identified as those elements that were induced or repressed
2-fold from the wild-type condition and that were regulated by IL-4 in an
independent microarray analysis comparing unstimulated and IL-4-stimu-
lated wild-type BMM. A second experiment using RNA from 16-h IL-4-
treated or untreated BMM (Tfec deficient or wild type) was performed
using Affymetrix Mouse430A_2 arrays. Hybridization, cRNA labeling,
and data handling were performed by Kompetenzzentrum fu¨r Fluoreszente
Bioanalytik.
Real-time PCR
Total RNA (2 g) was reverse-transcribed using SuperScript II (Invitrogen
Life Technologies). Real-time PCR was performed using the LightCycler
(Roche) with the Quantitect kit (Qiagen) according to the manufacturer’s
instructions. The primers used are given in Table I. Cycling parameters
were: denaturation at 95°C for 15 min and amplification at 95°C for 15 s,
57°C for 20 s, 72°C for 25 s for 55 cycles. The product size was initially
controlled by agarose gel electrophoresis, and melting curves were ana-
lyzed to control for the specificity of the PCRs. The relative units were
calculated from a standard curve with four different concentrations of log
dilutions to the PCR cycle number at which the measured fluorescence
intensity reaches a fixed value. Data were normalized against the house-
keeping genes Actb (Csf3r) and Hprt (all others). The amplification effi-
ciency (E) was calculated from the slope of the standard curve as: E 
101/slope. The observed primer efficiencies are given in Table I. All prim-
ers where chosen to amplify a cDNA fragment that includes intron-exon
borders in the corresponding genome sequence. The data from at least two
independent analyses for each sample were averaged.
Plasmid construction and purification
Cloning of a 615-bp fragment of the TFEC proximal promoter has been
described previously. Mutations of putative transcription factor binding
sites were conducted by PCR-mediated mutagenesis using the following
primers (mutated bases are underlined): NFB element, mTFEC-NFB_S
(5-CAG AGT CCA GTC GCT GCC CTA ATG G-3) and mTFEC-
NFB_AS (5-CCA TTA GGG CAG CGA CTG GAC TCT G-3); outer
STAT element, mTFEC-oS6M_S (5-CTG TCT AAT CTT CTT GTC
TAG ATC AAT TAT-3) and mTFEC-oS6M_AS (5-CCA AGA ATA
ATT GAT CTA GAC AAG AAG ATT-3); middle STAT element, mT-
FEC-mS6M_S (5-GGA CAG TGT TCT GAT CTA ACT TAC TTG
TAA-3) and mTFEC-mS6M_AS (5-TGC CTT ACA AGT AAG TTA
GAT CAG AAC ACT-3); and inner STAT element, mTFEC-iS6M_S
(5-CAT TGT AAA TTC TGG GCT CAA ATG TTT ATT-3) and mT-
FEC-iS6M_AS (5-CCC CAT AAT AAA CAT TTG AGC CCA GAA
TTT-3). DNA sequence analysis was performed by GENEART. For trans-
fections, plasmids were isolated and purified using the Endofree Plasmid
Kit (Qiagen).
Transient and stable DNA transfections
For transient reporter analysis, RAW264.7 cells were transfected using
SuperFect reagent (Qiagen) according to the manufacturer’s instructions as
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previously described (15). Duplicate transfections were harvested after
24 h, and cell lysates were assayed for firefly luciferase activity using the
Luciferase Reporter Assay System (Promega). The firefly luciferase activ-
ity of individual transfections was normalized against protein concentration
measured using a bicinchoninic acid assay (Sigma-Aldrich). For some ex-
periments, RAW264.7 cells were transfected in 10-cm tissue culture dishes
as described above using linearized reporter constructs (10 g) as well as
a plasmid carrying the neomycin resistance gene (5 g). Cells were se-
lected for stable integration of plasmid DNA by culturing cells in RPMI
1640 medium supplemented with 350 g/l G418 for 2–3 wk. Stably
transfected cells were pooled and expanded, and 750,000 cells/ml were
seeded into six-well plates in duplicate the day before stimulation. Cells
were harvested 5 h after stimulation, and cell lysates were assayed as de-
scribed above.
Nuclear extracts and EMSA
Nuclear extracts of RAW264.7 cells and BMM were prepared as described
previously (4). Double-stranded oligonucleotides corresponding to the
STAT6 or NFB elements were labeled with [-32P]dGTP using Klenow
DNA polymerase. Sequences of individual motifs are indicated in Figs. 5
and 6. The binding reaction contained 2.5 g of nuclear extract protein, 0.5
g of poly d(I/C), 20 mM HEPES (pH 7.9), 20 mM KCl, 1 mM DTT, 1
mM EDTA (pH 8.0), 5% glycerol, and 20 nmol of probe DNA in a final
volume of 10 l. Antisera used in supershift analyses were added after 15
min, and samples were loaded onto polyacrylamide gels after incubation at
room temperature for a total of 30 min. The buffers and running conditions
used have been described previously. Gels were fixed in 5% acetic acid,
dried, and autoradiographed.
Table I. Oligonucleotide primers used for LightCycler real-time PCR
Gene Primer Sequence (Sense and Antisense) Efficiency (E)
Arg1 5-GGA CTA GAT ATC ATG GAA GTG AAC CC-3 1.84
5-AGT CCC TGG CTT ATG GTT ACC C-3
Egr2 5-CCT TTG ACC AGA TGA ACG GAG TG-3 1.98
5-TGG TTT CTA GGT GCA GAG ATG GG-3
Klf4 5-CTG GCG AGT CTG ACA TGG C-3 1.94
5-CTC ACG CCA ACG GTT AGT CG-3
Etv3 (s) 5-AAC TTC AAC AAG CTC GTG ATG CC-3 1.97
5-GCT TCT AAA CAT CTC CTT ACA CGG G-3
Etv3 (l) 5-AAC TTC AAC AAG CTC GTG ATG CC-3 1.96
5-GAG AAT GGC TGT CTA GAG GTG GG-3
Trim30 5-AGC GAT CTC AGG AGC ACC G-3 1.94
5-TTC CAC AGA GCT CCC TGC AG-3
Csf3r 5-AGG GCT ATC TCA TTG AGT GGG-3 1.81
5-CTG TAA TTC TGT AGA GCT GAA AGG G-3
Bbx 5-CTT TTC TCA TCC GAT GGA TTC ACC-3 1.88
5-GAT GCC ACT GAA GAC ACT TCC G-3
Atp2a1 5-CCT CCT CCA TGT CTT TGA ACC G-3 1.94
5-TGA AGA TGC ATG GCT ATT GGG-3
Elavl4 5-ATC ATC ACC TCA CGC ATC CTG-3 1.91
5-TTG GCA AAC TTC ACA GTA ATC GG-3
Il17r 5-ACC ACA GCT GCT TTG ATG TCG-3 1.91
5-TGG TAT TTG AGA TTA CTG GGC AGG-3
Klk6 5-AAT GAC CTG ATG CTG CTC CG-3 1.85
5-TTT GGC ACA GTC CTC ATT AGG C-3
9830147J24Rik 5-AGA ATG ACT CGT GGA TCT TCG C-3 2.00
5-GAC CGT GAA GTG GAC TTT GCC-3
S100a9 5-CTC ATG GAC TGA TTA TGG ACA GGA C-3 2.00
5-ATG CAG CTT CTC ATG ACA GGC-3
F13a1 5-GGA TTC ATT TGG ATG GTC CTG G-3 1.91
5-GGA GTC ACT GGT CAT GCT GGC-3
Actb 5-TGA CGG GGT TCA CCC ACA CTG TGC CCA TCT A-3 1.83
5-CTA GAA GCA TTT GTG GTG GAC GAT GGA GGG-3
Hprt 5-ATG GTG GAA GCA CAG TTG GC-3 1.91
5-GCA GGT CAG CAA AGA ACT TAT AGC C-3
FIGURE 1. Flow cytometry. BMM from wild-type and Tfec-deficient mice (Tfec/) were analyzed by flow cytometry for the expression of the
indicated cell surface markers.
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Western blot analysis
The anti-Tfec rabbit polyclonal antiserum was raised against a GST fusion
protein with the C-terminal aa 199–317 of Tfec as described previously
(8). The antiserum showed no cross-reactivity against in vitro-translated
rMiT proteins Mitf, Tfe3, and Tfeb. For the detection of Tfec, whole cells
were lysed with SDS (1%) containing 1 mM Na3VO4 and a mixture of
protease inhibitors (2 g/ml aprotinin, 5 g/ml leupeptin, 1 g/ml pep-
statin, and 1 mM PMSF; Roche). To detect the G-CSFR, 106 cells were
lysed with Nonidet P-40 (1%) lysis buffer containing the above mixture of
phosphatase and proteinase inhibitors. Cell lysates were separated by SDS-
PAGE and blotted on a polyvinylidene difluoride membrane. Blots were
blocked overnight at 4°C with 5% milk powder/0.1% Tween 20/TBS and
incubated with anti-Tfec (1/200), anti-G-CSFR (1/500), or anti--actin an-
tisera (1/2000) and subsequently with HRP-conjugated goat anti-mouse Ab
(DakoCytomation) diluted 1/2500. Bands were visualized using ECL re-
agents (Amersham Biosciences), scanned, and analyzed using a Molecular
Dynamics personal densitometer (Amersham Biosciences).
Results
Normal phenotype of Tfec-deficient macrophages
Mice lacking Tfec develop normally and show no obvious histo-
logical alterations. Bone marrow cultures of both wild-type and
Tfec-deficient animals gave rise to similar numbers of macro-
phages in the presence of CSF-1, and the resulting cells were mor-
phologically indistinguishable (data not shown). A comparison of
wild-type and Tfec-deficient macrophages using flow cytometry
revealed that marker molecules F4/80-Ag, scavenger receptor,
CSF-1R (c-Fms), Mac-1, and Gr-1 were expressed at similar levels
(Fig. 1). This may indicate a redundant role for Tfec in normal
macrophage development.
Inducible expression pattern of Tfec in macrophages
Macrophages respond to a large number of environmental cues
with sometimes marked phenotypical and functional changes. To
investigate whether Tfec might be regulated during macrophage
activation, we treated BMM (BALB/c) with a number of cytokines
and proinflammatory stimuli to detect changes in Tfec mRNA ex-
pression. As shown in Fig. 2A, Tfec mRNA was markedly up-
regulated by the Th2 cytokines IL-4 and IL-13, GM-CSF, and
LPS. Several other mediators, including IL-1, TGF-, IFN-,
and IFN-, had no marked effect on Tfec mRNA expression. Sim-
ilar results were obtained using the macrophage cell line
RAW264.7 (Fig. 2B) and in macrophages from a genetically dif-
ferent background (129Sv/J), with the exception of GM-CSF,
which failed to induce Tfec expression in the macrophages from
129Sv/J mice (data not shown). The regulation by LPS and IL-4,
the archetypal inducers of classically and alternatively activated
macrophages, respectively, was further analyzed. As shown in
FIGURE 2. Northern analysis of inducible Tfec expression in macrophages. Total RNA was isolated from BALB/c BMM (A) and RAW264.7 cells (B)
treated for 4 or 24 h with the indicated stimuli and untreated (C) or treated with IL-4 (10 ng/ml) or LPS (1 g/ml) at 0 h for the indicated time periods.
D, Total RNA was isolated from BALB/c BMM, BMDC, and BMMC (cultured in the presence of CSF-1, GM-CSF, SCF/IL-4 (A) and SCF/IL-3 (B),
respectively), untreated or treated with IL-4 for 4 h. The blots were hybridized with a 32P-labeled Tfec cDNA. The ethidium bromide staining is shown
as a control for mRNA loading.
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Fig. 2B, LPS induced a rapid, but transient, up-regulation of Tfec
mRNA expression, whereas IL-4 treatment resulted in a rapid, but
long-lasting, increase in Tfec transcripts. Tfec mRNA induction
was dose dependent in both cases (data not shown). In a separate
study, one of the authors (D. A. Hume) and his colleagues in the
FANTOM3 consortium performed CAGE start site analysis on
BMM responding to LPS and CpG DNA (data not shown). The
data confirm the rapid, transient induction of Tfec and showed that
Tfeb is similarly expressed and regulated, whereas Tfe3 and Mitf
are expressed constitutively and are not further inducible.
To test whether IL-4 induction was cell type-specific, we gen-
erated BMDC as well as mast cells and stimulated the cultures
with IL-4. As shown in Fig. 2C, both myeloid cell types expressed
Tfec mRNA levels comparable to macrophages, and Tfec was in-
duced by IL-4 in both cases. No induction by IL-4, however, was
observed in NIH-3T3 fibroblasts (data not shown).
To follow the expression of Tfec protein during macrophage
activation, we generated a Tfec-specific antiserum that was sub-
sequently used to detect Tfec in Western analyses. The signals
were generally below the background staining in untreated and 6-h
stimuli-treated macrophages. A clear band with the expected m.w.
was reproducibly detected in macrophages that were treated with
IL-4 for 12 h (Fig. 3), but not in LPS-treated cells. Without a
defined standard, we cannot imply that there is no basal or LPS-
inducible Tfec protein in macrophages, but clearly, the levels are
significantly elevated by IL-4.
Analysis of LPS- and IL-4-mediated induction of Tfec
To analyze the regulatory mechanisms of LPS- and IL-4-induced
up-regulation of Tfec, we performed an analysis of the proximal
promoter of the Tfec gene. Initial transfection experiments indi-
cated that a luciferase construct of the proximal promoter was
responsive to LPS (but not IL-4) treatment in RAW264.7 cells.
Sequence analysis of the proximal human, rat, and mouse Tfec
promoter regions revealed the presence of a conserved NF-B mo-
tif in all three species (see Fig. 4). To determine the role of NF-B
in Tfec induction by LPS, we performed gel-shift experiments us-
ing nuclear extracts from untreated and LPS-treated RAW264.7
macrophages. As shown in Fig. 5A, the NF-B motif formed spe-
cific and inducible complexes with the NF-B family member p65.
To further confirm its role in LPS-mediated induction of promoter
activity, we mutated the conserved NF-B motif in the previously
described 615-bp promoter construct. As shown in Fig. 5B, muta-
tion of the NF-B element completely abolished LPS-induced re-
porter activity.
In RAW264.7 macrophages, the proximal promoter of Tfec did
not respond to IL-4 stimulation in stable (shown in Fig. 5B) and
transient (data not shown) transfections despite the presence of
three Stat6 consensus binding sites. However, as shown in Fig. 6B,
specific and inducible binding of nuclear Stat6 to two sites within
the proximal promoter was demonstrated in gel-shift experiments
FIGURE 3. Expression of Tfec protein is up-regulated in IL-4-treated
macrophages. Total cell lysates were prepared from BMM untreated or
treated with IL-4 (10 ng/ml) or LPS (1 g/ml) at 0 h for the indicated time
periods. Proteins were separated by SDS-PAGE and blotted. Western anal-
ysis was performed using a Tfec antiserum or an anti--actin mAb to
control for equal loading.
FIGURE 4. Sequence alignment
of human, rat, and mouse Tfec pro-
moter sequences. The 5-proximal
mouse Tfec promoter was aligned
with the corresponding rat and hu-
man promoter sequences. In humans,
two additional promoter regions may
exist. The region corresponding to
both murine promoters precedes exon
Ib of the human gene (7). Putative
binding sites for several transcription
factors that were identified using the
MatInspector database (Genomatix)
are indicated.
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using nuclear extracts from BMM. Welch et al. (16) reported that
RAW264.7 macrophages are defective in their IL-4 signaling path-
way in transfection assays. As shown in Fig. 6A, the IL-4 respon-
siveness was restored by cotransfecting an expression plasmid for
Stat6 as previously described by Welch et al. (16). The Tfec-pro-
moter construct was induced to a similar extent as a multi-
merized Stat6 site from the human 12/15-lipoxygenase promoter
(4STAT6-TK). Whereas the mutation of the outer (o) Stat6 el-
ement had no impact on the reporter activity of the Tfec promoter
construct, mutation of the middle (m) and the inner (i) site caused
a marked or complete reduction of IL-4-induced activation, re-
spectively (Fig. 6A). To unequivocally demonstrate that Stat6 was
required for IL-4 induction of Tfec transcription, we stimulated
macrophages from Stat6-deficient mice with IL-4 and compared
Tfec expression with corresponding wild-type macrophages. As
shown in Fig. 6C, Stat6-deficient macrophages did not induce Tfec
mRNA expression after treatment with IL-4.
Global analysis of IL-4-induced gene expression in BMM
The above data indicated that Tfec might act as a secondary tran-
scription factor of the IL-4 signaling cascade in macrophages
downstream of Stat6. To characterize the IL-4-induced expression
profile of alternatively activated macrophages and to identify those
genes that are regulated in a Tfec-dependent fashion, we compared
the transcriptome of IL-4-treated wild-type and Tfec-deficient
mouse macrophages using cDNA and oligonucleotide microarrays.
Because the protein product of the Tfec gene was induced with
delayed kinetics, we analyzed the transcriptome of macrophages
(both wild type and Tfec deficient) after 16-h treatment with IL-4.
The list of genes that were regulated by IL-4 in wild-type macro-
phages contained a number of genes that were previously de-
scribed as IL-4 regulated, including, e.g., arginase 1 (Arg1), dec-
tin-1 (Clecsf12), and Ym1 (Chi3l3) as well as Tfec. Microarray
results of wild-type macrophages are summarized in Fig. 7, A and
B. In comparison, most genes were almost identically regulated by
FIGURE 5. LPS induction of the proximal promoter
depends on a functional NF-B site. A, Labeled tfec-B
oligonucleotide was used in EMSA with nuclear pro-
teins (NE) from RAW264.7 macrophages untreated or
treated with LPS (1 g/ml) for 30 min. Addition of un-
labeled oligonucleotides for competition analysis (lanes
4–6) or antiserum against p65 (lane 7) is indicated
above each lane. p65-containing complexes are marked
with an arrow, the Ab supershift with SS, and unspecific
complexes with an asterisk. B, Mouse RAW264.7 cells
were stably transfected with the indicated constructs.
Five hours before harvesting, cells were treated as indi-
cated (IL-4, 10 ng/ml; LPS, 1 g/ml). Induction of lu-
ciferase activity is shown relative to activities for un-
treated cells (fold induction). Values are the mean  SD
obtained from three independent experiments.
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FIGURE 6. IL-4-induction of Tfec mRNA is STAT6
dependent. A, Mouse RAW264.7 cells were transiently
transfected with the indicated constructs as well as a
Stat6 expression plasmid. Sixteen hours before harvest-
ing, cells were treated with IL-4 (20 ng/ml). Induction of
luciferase activity is shown relative to the activity of the
empty pGL3-B vector. Values are the mean  SD ob-
tained from three independent experiments. B, Labeled
tfec-Stat6i and tfec-Stat6m oligonucleotides were used
in EMSA with nuclear proteins (NE) from BMM un-
treated or treated with IL-4 (10 ng/ml) for 2 h. Addition
of unlabeled oligonucleotides for competition analysis
(lanes 3 and 4) or antisera against Stat factors (lanes 5
and 6) is indicated above each lane. Stat6-containing
complexes are marked with an arrow, Ab supershifts
with SS, and unspecific complexes with an asterisk. C,
Northern analysis of IL-4-inducible Tfec expression in
Stat6-deficient macrophages. Total RNA was isolated
from wild-type (wt) and Stat6-deficient (Stat6/)
BMM untreated or treated with IL-4 (10 ng/ml) at 0 h
for the indicated time periods. The blots were hybridized
with a 32P-labeled Tfec cDNA. The ethidium bromide
staining is shown as a control for mRNA loading.
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IL-4 in Tfec-deficient macrophages. Microarray signals of only a
small number of genes (listed in Fig. 7, C–F) were significantly
altered in mutant macrophages.
To further validate the results obtained by microarray analysis,
we analyzed the expression of several genes that were either reg-
ulated in wild-type macrophages or affected in Tfec-deficient an-
imals using LightCycler real-time PCR. In wild-type macrophages
we focused on transcription factors that were novel targets of IL-4,
including early growth response 2 (Egr2, Krox20), Krueppel-like
factor 4 (Klf4, Gklf), ets variant gene 3 (Etv3, PE1/Mets), and
Trim30. As shown in Fig. 8A–E, all four factors showed an ex-
pression pattern similar to the one observed using microarrays.
The effect of Tfec deficiency on genes identified by microarray
analysis was generally less reproducible by real-time PCR analy-
sis. Expression profiles of several genes (S100a9, see Fig. 8G;
IL17r, see Fig. 8I; Atp2a1, Elavl4, F13a1, and 9830147j24Rik,
data not shown) as determined by LightCycler PCR in three bio-
logically independent samples were not significantly altered in
Tfec-deficient macrophages. Only a small number of genes were
significantly and reproducibly altered in Tfec-deficient macro-
phages, including the previously uncharacterized transcription fac-
tor bobby sox homologue (Bbx, shown in Fig. 8F), the G-CSFR
(Csf3r, shown in Fig. 8J), and the serine protease kallikrein 6
(Klk6, shown in Fig. 8H). Because a regulated expression of the
G-CSFR in macrophages has not previously been reported, this
gene was chosen for detailed study. Based upon the array data
(Fig. 7F), the level of G-CSFR mRNA in IL-4-treated, Tfec-defi-
cient macrophages was significantly reduced (2-fold) compared
with that in IL-4-treated, wild-type macrophages. To confirm the
Tfec-dependent regulation of the Csf3r gene, real-time PCR was
performed using wild-type and Tfec-deficient BMM untreated or
treated with IL-4 for up to 16 h. As shown in Fig. 8J, the IL-4-
dependent induction of the Csf3r gene was markedly reduced in
Tfec-deficient macrophages. In contrast, the induction of another
known IL-4 target gene in macrophages, arginase 1 (Arg1), was
unaffected by the Tfec-mutation (Fig. 8K). To investigate whether
the G-CSFR protein was also induced by IL-4 in a Tfec-dependent
fashion, we performed Western analyses using membrane lysates
from wild-type and Tfec-deficient BMM untreated or treated with
IL-4 for up to 30 h. As shown in Fig. 8, L and M, G-CSFR protein
was indeed induced after 20-h treatment with IL-4, and the extent
of induction was markedly reduced in Tfec-deficient macrophages.
Discussion
The identity and function of differentiated cells are determined by
the concerted action of ubiquitous and, most importantly, cell type-
specific transcription factors. We showed previously that the
bHLH transcription factor Tfec is specifically expressed in mouse
mononuclear phagocytes, indicating a possible role for Tfec in the
development or function of these cells (4). The present report fur-
ther investigates the regulation and function of Tfec in activated
macrophages. Upon stimulation, the most striking effects on Tfec
levels were observed in IL-4-treated, alternatively activated mac-
rophages. Both mRNA and protein were markedly up-regulated,
suggesting a role for Tfec in regulating the alternative activation
program in macrophages or dendritic cells. We also identified the
first three putative target genes of Tfec in IL-4-treated macro-
phages, which include the Csf3r gene encoding the G-CSFR.
Based on mRNA expression studies of several macrophage and
nonmacrophage cell types and an initial characterization of the
proximal mouse Tfec promoter, our previous studies indicated a
restricted expression of the mouse transcription factor Tfec in mac-
rophages (4). The TATA-less promoter of Tfec shares features
with many known macrophage-specific promoters and preferen-
tially directed luciferase expression in the RAW264.7 macrophage
cell line in transient transfection assays. Tfec expression probably
depends on the myeloid and B cell-specific transcription factor
PU.1, because several PU.1 motifs identified in the Tfec promoter
bound PU.1 under in vitro conditions, and coexpression of PU.1
induced luciferase activity of the Tfec promoter in transfected
NIH-3T3 fibroblasts (4). Mice lacking Tfec are indistinguishable
from their wild-type littermates; they are viable and fertile, nor-
mally pigmented, have normal eyes and mast cells, and show no
osteopetrosis, indicating that other MiT family members may com-
pensate for Tfec deficiency under normal standard conditions (10).
The normal phenotype of Tfec-deficient mice is surprising, be-
cause the expression pattern of Tfec is highly cell type specific. In
humans, according to two reference databases for gene expression
(LSBM: www.lsbm.org/site_e/database/index.html or GNF Sy-
mAtlas: symatlas.gnf.org), TFEC mRNA expression appears
even more macrophage restricted than many other macrophage
markers, including PU.1. Given that the effect of Mitf mutation in
mice is dependent upon genetic background, it is possible that Tfec
deficiency would have a greater effect if backcrossed to distinct
inbred strains.
In this study we considered the possibility that Tfec functions
not in macrophage differentiation, but in some function associated
with innate or acquired immunity. We studied the modulation of
Tfec expression in macrophages treated with different pro- and
anti-inflammatory mediators and found that Tfec expression at
both the mRNA and protein levels is strongly induced in mouse
macrophages by the Th2 cytokine IL-4. IL-4 also induced Tfec
expression in two other PU.1-expressing cell types: myeloid
BMDC and BMMC. As an important role for the MiT family
member microphthalmia transcription factor (Mitf) has been dem-
onstrated in mast cell biology, it will be interesting to study the
role of Tfec in mast cells treated with IL-4. The apparent delay in
Tfec protein expression in IL-4-treated macrophages and the ab-
sence of detectable Tfec protein in LPS-stimulated macrophages
despite the up-regulation of Tfec mRNA may indicate that IL-4
positively regulates Tfec at the level of protein stability in addition
to the transcriptional level.
IL-4 (and IL-13) are generally produced in Th2-type responses,
particularly in allergic, cellular, and humoral responses to extra-
cellular and parasitic pathogens (17). They are known to induce an
alternative activation program in macrophages that is distinct from
the classical activation induced by the Th1 cytokine IFN- (13).
Recently, it was demonstrated that IL-4R signaling and hence the
generation of alternatively activated macrophages are critical for
host survival during schistosomiasis (18). The alternative activa-
tion program includes the up-regulation of several receptors in-
volved in phagocytosis (e.g., mannose receptor (19) or dectin-1
(20)) and Ag presentation (e.g., MHC class II molecules) (21).
Alternatively activated macrophages are known to produce a dis-
tinct set of chemokines (e.g., CCL17 and CCL22) (22, 23) and
FIGURE 7. Microarray analysis of IL-4-dependent and independent gene regulation in wild-type and Tfec-deficient macrophages. A and B, Microarray
detection of transcripts that increased (A) or decreased (B) at least 3-fold by wild-type BMM in response to recombinant mouse IL-4 (10 ng/ml). C–F,
Comparison of transcript levels from wild-type (wt) and Tfec-deficient (Tfec/) BMM either untreated (D and E) or treated with IL-4 for 16 h (C and
F). Transcripts that were further analyzed by real-time PCR are highlighted.
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intracellular enzymes (e.g., arginase 1) (24), and responses to mi-
crobial stimulation are different from classically activated macro-
phages in terms of cytokine release and production of reactive
oxygen species (13). Our analysis of Tfec function entailed the first
global analysis of IL-4-induced gene regulation in alternatively
activated macrophages. We identified most of the previously char-
acterized IL-4 target genes in macrophages and, in addition, char-
acterized a new set of genes that may play a role in the biology of
alternatively activated macrophages.
As expected, many of the identified genes were inversely reg-
ulated in IL-4-stimulated compared with IFN--activated macro-
phages, including Socs1 and Socs2 (up-regulated by IL-4), Stat1
(down-regulated by IL-4), and a large number of LPS- or IFN-
inducible genes, e.g., Ip10, TLR2 (Tlr2), dsRNA-activated kinase
(PKR, Prkr), or Cd14 (all down-regulated by IL-4).
A number of IL-4 target genes in macrophages have previously
been identified on dendritic cells, including the B7 family mem-
bers B7DC (Pdcd1lg2) and B7H1 (Pdcd1lg1), and the Cd83 Ag.
Interestingly, IL-4 also induced three endothelial cell markers in
macrophages: E-cadherin (Cdh1), vascular endothelial growth fac-
tor receptor (Flt1), and von Willebrand factor (Vwf). Expression of
these markers was previously noted in human immature dendritic
cells that develop into endothelial-like cells when cultured in the
presence of angiogenic growth factors (25).
Notably, we identified several transcription factors that are in-
duced by IL-4, including, e.g., msh-like homeobox gene 3 (Msx3),
early growth response 2 (Egr2, Krox20), bHLH transcription fac-
tor STRA13/Dec1 (Bhlhb2), IL-3-induced NF (Nfil3), Krueppel-
like factor 4 (Klf4, Gklf), basic transcription element-binding pro-
tein 1 (Bteb1), and ets variant gene 3 (Etv3, PE1/Mets). It is
conceivable that these transcription factors serve as secondary reg-
ulators of IL-4 signaling in macrophages and in some measure
complement a Tfec deficiency. STRA13/Dec1, in particular, is an-
other E box-binding protein that has been implicated in the regu-
lation of STAT3 activity (26). It will be interesting to analyze their
contributions to the phenotype of alternatively activated macro-
phages. In addition to Th2-type environments, tumors can induce
an alternative activation macrophage phenotype (27). Tfec was
originally cloned from a rat chondrosarcoma; however, no expres-
sion was detected in the respective chondrosarcoma cell line (5). It
is therefore conceivable that Tfec is also induced in tumor-asso-
ciated macrophages. The same might also be true for the above-
mentioned transcription factors. Clearly, further studies are needed
FIGURE 8. Comparative analysis of gene regulation on single gene level in wild-type and Tfec-deficient macrophages. A–K, Real-time quantitative
RT-PCR (LightCycler) for the indicated genes was performed on cDNAs prepared from wild-type (wt) and Tfec-deficient (Tfec/) BMM, either untreated
or treated with recombinant mouse IL-4 (10 ng/ml) at 0 h for the indicated time periods. LightCycler results were normalized to housekeeping genes Hprt
(A–I) or Actb (J and K) expression. Data represent the mean  SD of three independent preparations of BMM. L, Western analysis of G-CSFR protein
levels in membrane extracts from untreated or IL-4-treated wild-type (wt) and Tfec-deficient (Tfec/) BMM. -Actin was stained to control for equal
loading. M, Densitometric evaluation of G-CSFR protein expression. Signal intensities were normalized against -actin, and values are relative to the band
intensity of untreated wild-type macrophages.
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to elucidate the role of these factors in tumor-associated
macrophages.
To identify potential target genes of IL-4-induced Tfec in alter-
natively activated macrophages, we compared the expression pro-
files of IL-4-treated macrophages from wild-type and Tfec-defi-
cient mice. Our LightCycler real-time PCR results indicate that
only a small set of genes is differentially regulated, including the
bobby sox homologue (Bbx), Etv3 (short variant), G-CSFR
(Csf3r), and kallikrein 6 (Klk6). Apparently, macrophages are
largely able to compensate for Tfec deficiency. It needs to be clar-
ified whether Tfec directly or indirectly regulated the above genes.
The expression profile of the G-CSFR gene was further ana-
lyzed. Up-regulation of the G-CSFR in alternatively activated
macrophages has not been previously described and represents an
interesting and potentially relevant finding in itself. It is clear that
G-CSF is an essential factor for neutrophil development (28), but
the actions of this cytokine on mononuclear phagocytes are not
well defined. Low level expression of G-CSFR on mouse macro-
phages (29) as well as on human monocytes (30) has been dem-
onstrated. In humans, the administration of G-CSF increased the
expression of CR1, CR3, FcRI, and FcRIII on monocytes (31).
Other studies indicate that G-CSF attenuates monocytic IL-12 and
TNF release upon stimulation with LPS (30). Studies of G-CSF-
deficient peritoneal mouse macrophages demonstrated a strong ef-
fect of G-CSF deficiency on macrophage activities and numbers
(32). Our results show that the G-CSFR is strongly induced on
macrophages by the Th2 cytokine IL-4, suggesting that G-CSF
might specifically act on alternatively activated macrophages. It
was also shown that G-CSF augments IL-4 secretion by T lym-
phocytes (33), indicating a role for G-CSF in Th2 immune re-
sponses. It is possible that the neutrophil growth factor G-CSF
plays an additional, but as yet unrecognized, role in the biology
and function of alternatively activated macrophages. A secondary
issue that arises from a role for Tfec in G-CSFR production is that
Tfec might have a role in granulocyte differentiation. Many gran-
ulocyte promoters also possess PU.1 sites, and PU.1 deficiency
also ablates granulocyte production in mice (34, 35). Although the
Tfec-deficient mice are not grossly granulocyte deficient, a de-
tailed study of this lineage might reveal another role for Tfec.
In conclusion, we provide a global analysis of transcripts ex-
pressed by IL-4-treated mouse macrophages. We show that Tfec,
along with several other transcription factors, is a Stat6-dependent
target of IL-4. Tfec deficiency appears to have a mild impact on
IL-4-induced gene expression, affecting only a few genes. Inter-
estingly, Tfec participates in the IL-4 induction of the G-CSFR that
is strongly induced on alternatively activated macrophages. Our
results will inform further studies of the impact of the newly iden-
tified IL-4 targets as well as Tfec and G-CSFR up-regulation in
macrophages in both tumor and Th2-type environments.
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